352 material Form 8-K filings that 310 companies we cover made with the SEC in August 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
e.l.f. Beauty's board authorized a new share repurchase program of up to $500 million of common stock, replacing a $25 million program from 2019 that has been exhausted. The company also amended its credit agreement to increase capacity for restricted payments, such as share repurchases, subject to a pro forma net leverage ratio test. Shareholders also elected three Class II directors and approved officer exculpation and executive compensation at the August 22, 2024 annual meeting.
New share repurchase program authorizes up to $500 million of common stock, with no expiration date and no required minimum purchases.
Prior $25 million program, announced in May 2019, is exhausted after about $17 million in repurchases over the past two weeks.
Third Amendment to the credit agreement, dated August 26, 2024, raises restricted payment capacity subject to a pro forma net leverage ratio test.
At the August 22, 2024 annual meeting, shareholders approved officer exculpation (37,234,458 for) and advisory executive compensation (40,676,556 for).
UFP Industries said its board appointed William D. Schwartz as chief executive officer effective December 29, 2024, and named current CEO Matthew J. Missad as executive chairman on the same date. The changes are a planned succession, and Missad has agreed to serve as executive chairman through 2026. The filing discloses pay changes for both men but no changes to reported financial results.
William D. Schwartz, currently president of UFP Retail, will become CEO on December 29, 2024, with base salary rising to $600,000 per year
Matthew J. Missad, CEO since July 2011, becomes executive chairman on December 29, 2024, at a base salary of $500,000 per year
Missad has agreed to remain executive chairman through 2026 and will assist with shareholder relations
CFO Michael Cole will add the title of President of Corporate Services
Arcus Biosciences entered a Loan and Security Agreement with Hercules Capital on August 27, 2024, providing a secured term loan facility of up to $250.0 million. Only $50.0 million was funded at closing, with the rest available under later tranches at the company's option or the lenders' option, and the loans are secured by substantially all company assets.
$50.0 million funded on August 27, 2024; up to $150.0 million more available at the company's option through March 15, 2026, and a further $100.0 million at the lenders' option
Interest at the greater of Prime Rate plus 1.95% or 10.45%; interest-only payments until September 1, 2028; maturity September 1, 2029
Financial covenant requires Qualified Cash of at least 50% of outstanding principal when market capitalization is at or below $1.20 billion, with reductions upon milestones
Insperity's longtime chief financial officer, Douglas S. Sharp, will retire on November 15, 2024, after 21 years in the role. James D. Allison, currently executive vice president of comprehensive benefit solutions and chief profitability officer, will succeed him as CFO on the same date, and Sean P. Duffy will be promoted to senior vice president of finance and accounting.
Douglas S. Sharp retires as CFO effective November 15, 2024, after serving as CFO for 21 years
James D. Allison, who joined Insperity in 1997, becomes executive vice president of finance, CFO and treasurer on November 15, 2024, with his annual salary increased to $550,000
Sean P. Duffy is promoted to senior vice president of finance and accounting, with a salary of $375,000 and a special award of 5,100 restricted stock units vesting in annual thirds
Box reported fiscal second-quarter 2025 results for the quarter ended July 31, 2024, with revenue of $270.0 million, up 3% from $261.4 million a year earlier, and GAAP diluted EPS of $0.10 versus $0.04. The board also expanded the stock repurchase program by $100 million on August 25, 2024, and the company gave revenue and EPS guidance for the third quarter and full fiscal 2025, which includes a deferred tax expense in the United Kingdom.
Q2 revenue of $270.0 million, up 3% (6% in constant currency); RPO of $1.272 billion, up 12%
Non-GAAP diluted EPS was a record $0.44 versus $0.36; GAAP diluted EPS was $0.10 versus $0.04
Q3 revenue guidance of $274 million to $276 million; FY25 non-GAAP EPS guidance of $1.64 to $1.66
Board authorized a $100 million expansion of the stock repurchase program on August 25, 2024; about $25 million of prior capacity remained at July 31, 2024
REX American Resources reported fiscal second-quarter 2024 results for the three months ended July 31, 2024. Diluted earnings per share rose to $0.70 from $0.52 a year earlier, but net sales and revenue fell to $148.2 million from $212.0 million, mainly due to lower ethanol and co-product pricing. The company also said construction of its One Earth Energy carbon capture facility will run past its previously expected end-of-July completion timeframe.
Net income attributable to REX shareholders was $12.4 million, compared with $9.1 million a year earlier.
Net sales and revenue were $148.2 million, down from $212.0 million, and gross profit rose to $19.8 million from $18.4 million.
The company had $346.0 million of cash, cash equivalents and short-term investments and no bank debt as of July 31, 2024.
EPA projects a draft permit for the carbon capture project by the end of 2024, with a final permit decision in the second quarter of 2025.
ScanSource reported fourth-quarter and fiscal 2024 results for the year ended June 30, 2024, with net sales down 21.2% in the quarter and 13.9% for the year, and GAAP diluted EPS down year over year. The company also issued its first fiscal 2025 outlook, projecting net sales of $3.1 billion to $3.5 billion and adjusted EBITDA of $140 million to $160 million, and said it completed two acquisitions in August 2024.
Q4 fiscal 2024 net sales were $746.1 million, down 21.2%, and GAAP diluted EPS was $0.64 versus $0.68 a year earlier.
Fiscal 2024 GAAP diluted EPS was $3.06 versus $3.47, and operating cash flow was $371.6 million versus a $35.8 million outflow.
FY25 outlook: net sales $3.1 billion to $3.5 billion, adjusted EBITDA $140 million to $160 million, and free cash flow of at least $70 million.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.